InsightsPremium

David C. Stump

Director at Portola Pharmaceuticals

David Stump, M.D., was most recently executive vice president, research and development at Human Genome Sciences, Inc., serving there from November 1999 until December 2012. Prior to joining Human Genome Sciences, Dr. Stump held roles of increasing responsibility at Genentech, Inc., from 1989 to 1999, most recently as vice president, clinical research, and was named a Genentech Fellow in 1996. Prior to joining Genentech, Dr. Stump was an associate professor of medicine and biochemistry at the University of Vermont. He is a member of the board of directors of Sunesis Pharmaceuticals, Inc., REGENXBIO, Inc., and MacroGenics Inc., and is a member of the board of trustees of Earlham College. He earned a B.A. from Earlham College and an M.D. at Indiana University, followed by residency and fellowship training in internal medicine, hematology and oncology, and biochemistry at the University of Iowa, then by further postgraduate training in hemostasis and thrombosis at the University of Leuven, Belgium. He is board certified in internal medicine, hematology, and medical oncology, and is a Fellow of the American College of Physicians and the Council on Arteriosclerosis, Thrombosis, and Vascular Biology of the American Heart Association.

Roles

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.